IP Library Granted Patent US 8,664,357
Granted Patent B2
US 8,664,357 · App. 13/058,002 · Granted Mar 4, 2014

Solvent resistant diafiltration of peptides, PNA or oligonucleotides

Inventors: Andrew Guy Livingston (Knebworth, GB); Ludmila Georgieva Peeva (London, GB); Sheyung Wang Jerry So (London, GB); Renato Campos Vasconceles (London, GB); Robin John Leatherbarrow (Horne Horley, GB); Edward William Tate (London, GB); Piers Robert James Gaffney (London, GB)
Assignee: Imperial Innovations Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,664,357
App. No.
13/058,002
Granted
Mar 4, 2014
Kind
B2
Abstract

According to the present invention, there is provided a process for the preparation of a first compound selected from peptides, oligonucleotides and peptide nucleic acids. The process comprises synthesizing the first compound and then separating the first compound formed in step (i) from a second compound, which is a reaction by-product of the synthesis of the first compound and/or an excess of a reagent used for the synthesis of a first compound by a process of diafiltration. The membrane used for the diafiltration process is stable in organic solvents and provides a rejection for the first compound which is greater than the rejection for the second compound.

Claims (15)

1. A process for the preparation of a first compound selected from peptides, oligonucleotides, and peptide nucleic acids; the process comprising: (i) synthesising the first compound by liquid phase synthesis in an organic solvent; and (ii) separating the first compound formed in step (i) from a second compound, which is a reaction by-product of the synthesis of the first compound and/or an excess of a reagent used for the synthesis of the first compound, wherein (a) the synthesis of the first compound in step (i) involves one or more coupling or deprotection reactions; (b) the first and second compounds are dissolved in an organic solvent and are separated by a process of diafiltration using a membrane that is stable in the organic solvent and which provides a rejection for the first compound which is greater than the rejection for the second compound; and (c) the process comprises subjecting the first compound to one or more coupling and/or deprotection reactions subsequent to separation.

2. A process according to claim 1 , wherein the organic solvent for the liquid phase synthesis is the same as that used for the diafiltration.

3. A process according to claim 1 , which further comprises purifying the product of (c) using a diafiltration process as defined in step (ii).

4. A process according to claim 1 , wherein the membrane is a polymeric membrane.

5. A process according to claim 1 , wherein the membrane is a ceramic membrane.

6. A process according to claim 1 , wherein the membrane is a mixed matrix organic/inorganic membrane.

7. A process according to claim 1 , wherein the first compound is attached to a support.

8. A process according to claim 7 , wherein the support is a polymer support.

9. A process according to claim 8 , wherein the support comprises a dendrimer or hyperbranched polymer.

10. A process according to claim 7 , wherein the support is an organic or inorganic nanoparticle.

11. A process according to claim 1 , wherein the first compound has a molecular weight greater than 500 daltons.

12. A method of use of a filtration membrane for the preparation of a first compound selected from peptides, oligonucleotides, and peptide nucleic acids; the method comprising:

(i) synthesising the first compound;

(ii) separating the first compound formed in step (i) from an organic solvent and a second compound, which is a reaction by-product of the synthesis of the first compound and/or an excess of a reagent used for the synthesis of the first compound, wherein the first and second compounds are dissolved in an organic solvent and are separated by a process of diafiltration using a membrane that is stable in the organic solvent and which provides a rejection for the first compound which is greater than the rejection for the second compound; and

(iii) subjecting the first compound to one or more coupling and/or deprotection reactions subsequent to separation.

Assignments (2)
CHANGE OF NAME Recorded Feb 19, 2020
From: IMPERIAL INNOVATIONS LIMITED
To: IP2IPO INNOVATIONS LIMITED
Reel/Frame 051864/0144 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2014
From: LIVINGSTON, ANDREW GUY; PEEVA, LUDMILA GEORGIEVA; JERRY SO, SHEYUNG WANG; VASCONCELES, RENATO CAMPOS; LEATHERBARROW, ROBIN JOHN; TATE, EDWARD WILLIAM; JAMES GAFFNEY, PIERS ROBERT
To: IMPERIAL INNOVATIONS LIMITED
Reel/Frame 032024/0038 →
Priority Claims (1)
GB 0814519.5 · Aug 8, 2008 · national
Continuity (1)
Related Publication 20110245460A1 · Oct 6, 2011